SDB-005 is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. It is presumed to be an agonist of the CB1 and CB2 cannabinoid receptors. SDB-005 is the indazole core analogue of PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group.
It’s new cannabinoid
IUPAC name: 1-pentyl-1H-indazole-3- carboxylic-acid-naphthalen-1-yl ester
CAS number: 99312-12-2
Purity: 99,6% min
Appearance: white powder
The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic purposes.